In plain English
IGF-1 DES is a version of IGF-1, the growth factor that carries out much of growth hormone’s work, with its first three amino acids removed. That small change makes it act faster and more strongly in the tissue where it is injected, but it is cleared quickly.
What it's used for
- Local muscle growth in a trained area
- Recovery after training
- Muscle repair
Benefits
In laboratory and animal studies, IGF-1 DES was several times more potent than regular IGF-1, because it does not bind the proteins that normally hold IGF-1 inactive in the blood. Users report fuller, faster-recovering muscles when it is injected into the area trained that day.
How it works
In simple terms: IGF-1 DES is a fast, local version of IGF-1 that acts right where it is injected.
It binds the IGF-1 receptor, which tells muscle cells and their stem cells (satellite cells) to grow and divide. Without its first three amino acids, it escapes IGF-binding proteins, so it is more active but lasts only a short time.
Development history
- 1980s: Found naturally in the brain, colostrum and other tissues.
- Later: Made synthetically for research and adopted by users for site-specific muscle work.
Typical protocols
These ranges are what users commonly report.
| Use | Dose | Timing | Length |
|---|---|---|---|
| Local muscle growth | 50–150 mcg, split between muscles trained | Right after training, training days only | 4–6 weeks |
Cycling
Commonly run for 4–6 weeks, then a break of similar length.
Administration options
Injected into or near the muscle just trained (intramuscular or subcutaneous).
Reconstitution and dosing calculator
Usually comes in 1 mg vials. Some users mix it with a weak acid solution (0.6% acetic acid) to keep it stable; bacteriostatic water is also used. A 1 mg vial with 2 mL gives 500 mcg per mL.
Draw your syringe to
– units
- Volume to draw
- –
- Concentration
- –
- Each unit holds
- –
- Doses per vial
- –
Show the math
This tool does arithmetic only. It does not choose a dose or confirm that any substance is right for you. Double-check every result against your syringe and your clinician’s instructions.
Side effects and safety
- Low blood sugar is the main risk: eat a meal with carbohydrates soon after dosing.
- Injection-site redness and soreness.
- People with active cancer are usually advised to avoid growth factors and growth hormone-raising compounds.
- Avoid during pregnancy and breastfeeding.
- Prohibited in competitive sport (WADA).
Common stacks
- Growth hormone peptides such as CJC-1295 and ipamorelin: often run alongside.
- MGF: some users alternate the two.
Storage
Powder: refrigerate or freeze. After mixing: refrigerate at 2–8 °C and use within about 3–4 weeks.
Compare with
- IGF-1 LR3: lasts much longer and acts throughout the body; IGF-1 DES is short and local.
- MGF: a related growth factor triggered by muscle damage.
Frequently asked questions
IGF-1 DES or IGF-1 LR3?
DES acts fast and locally, right after training. LR3 lasts most of a day and acts throughout the body.
Why eat after dosing?
IGF-1 lowers blood sugar, so users eat carbohydrates soon after to avoid feeling shaky or faint.
References
- Francis GL, et al. Insulin-like growth factors 1 and 2 in bovine colostrum. Sequences and biological activities compared with those of a potent truncated form. Biochem J. 1988;251(1):95-103.